- Home
- TXN vs LLY Comparison
TXN vs LLY Comparison
Compare TXN & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXN | LLY |
|---|---|---|
| Founded | 1930 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.9B | 950.7B |
| IPO Year | 2000 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TXN | LLY |
|---|---|---|
| Price | $191.08 | $981.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 19 |
| Target Price | $217.13 | ★ $1,174.53 |
| AVG Volume (30 Days) | ★ 5.6M | 2.4M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.86% | 0.69% |
| EPS Growth | 4.81 | ★ 95.99 |
| EPS | 5.45 | ★ 22.95 |
| Revenue | $17,682,000,000.00 | ★ $65,179,000,000.00 |
| Revenue This Year | $11.66 | $27.04 |
| Revenue Next Year | $10.41 | $16.26 |
| P/E Ratio | ★ $36.47 | $43.54 |
| Revenue Growth | 13.05 | ★ 44.70 |
| 52 Week Low | $139.95 | $623.78 |
| 52 Week High | $231.32 | $1,133.95 |
Technical Indicators
Market Signals| Indicator | TXN | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 32.29 | 40.93 |
| Support Level | $174.78 | $978.77 |
| Resistance Level | $192.92 | $1,102.49 |
| Average True Range (ATR) | 5.24 | 24.83 |
| MACD | -2.85 | -2.91 |
| Stochastic Oscillator | 2.74 | 15.28 |
Price Performance
Historical ComparisonAbout TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.